Medidata Edge Strategic Monitoring Wins “Best Sponsor-Focused Technological Development” at CARE Awards 2018
04/27/2018
Company Celebrates Third Consecutive Informa CARE Award Win
April 27, 2018 - NEW YORK - Medidata (NASDAQ: MDSO) is pleased to announce that its risk based monitoring solution, Edge Strategic Monitoring, won an Informa Clinical and Research Excellence (CARE) Award, marking the third consecutive year the company earned this distinction. The CARE Awards acknowledge and applaud the pharmaceutical industry’s outstanding innovators across all areas of the industry, recognizing both corporate and individual achievements.
Medidata Edge Strategic Monitoring was selected in the “Best Sponsor-focused Technological Development” category. Available as part of the Medidata Clinical Cloud®, Medidata Edge Strategic Monitoring is the first and only end-to-end solution that combines advanced anomaly detection, powered by machine learning algorithms, with centralized issue management. The solution helps find known and unknown risks and take action in real-time.
“Medidata’s Strategic Monitoring suite is an exciting end-to-end solution to support effective risk- based monitoring and workflow, an area where many companies have developed only partial solutions,” said the CARE Awards judges. “It enriches data quality through early, real-time, unique insights, and is the only technology that adheres to ICH E6 guidelines as well as TransCelerate’s RBM Functional Requirements.”
''This CARE Award recognition reinforces our technology vision and innovation. I’m proud of our team for paving the way for sponsors and CROs to take on a new risk-based approach from one unified platform,'' said Glen de Vries, co-founder and president of Medidata. “Our comprehensive Edge Strategic Monitoring solution is the most complete offering to address ICH E6 guidelines and de-risk the regulatory submission.”
The CARE Awards are managed by Informa Pharma Intelligence, the world’s leading provider of drug, device, company, clinical trial and market intelligence in the competitive pharma and medtech markets.
About Medidata
Medidata's unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. The Medidata Clinical Cloud® connects patients, physicians and life sciences professionals. Companies on the Medidata platform are individually and collaboratively reinventing the way research is done to create smarter, more precise treatments. For more information: www.mdsol.com
Medidata Solutions
Investors:
Betsy Frank, 917-522-4620
bfrank@mdsol.com
or
Media:
Erik Snider, 646-362-2997
esnider@mdsol.com